The authors show that the silencing of IDO-2, achieved through a small interfering RNA (siRNA), inhibits the proliferation of tumor cells, stops the cell cycle in G1, induces greater cell apoptosis and reduces cell migration in vitro. Here, IDO2 is linked to neoplasm.